News Trump's DOJ reschedules medicinal marijuana, increasing acce... The US Justice Department has issued an order moving medical marijuana to Schedule III, removing some barriers to access for patients and researchers.
R&D The evolving landscape of medicinal cannabis and its synergy... The journey of medicinal cannabis has seen remarkable adoption worldwide.
News Astellas pays $285m for Audax cancer drug, and other deals Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.